Table 3.

Standardized incidence ratios for different types of cancer developed after renal transplantation from 2010 to 2014 in South Korea

All cancer	Total patients				Males				Females
	Obs.	Exp.	SIR	95% CI	Obs.	Exp.	SIR	95% CI	Obs.	Exp.	SIR	95% CI
	104	29.35	3.54	2.89–4.29*	63	19.32	3.26	2.51–4.17*	41	10.16	4.04	2.90–5.47*
Thyroid	24	5.24	4.58	2.94–6.82*	12	1.25	9.57	4.94–16.71*	12	3.00	4.00	2.06–6.98*
Kidney	9	0.55	16.31	7.44–30.95*	7	0.49	14.15	5.67–29.15*	2	0.12	16.68	1.87–60.23*
Stomach	7	4.11	1.71	0.68–3.51	7	3.58	1.95	0.78–4.03
Liver	6	2.19	2.74	1.00–5.97*	5	2.11	2.37	0.76–5.53	1	0.39	2.54	0.03–14.13
Lung	6	3.34	1.79	0.66–3.91	5	2.73	1.82	0.59–4.27	1	0.64	1.56	0.02–8.66
Breast	6	2.22	2.70	0.99–5.88*					6	1.56	3.85	1.41–8.39*
Leukemia	4	0.15	27.08	7.28–69.32*	2	0.26	7.78	0.87–28.10*	2	0.10	19.26	2.16–69.54*
Skin	4	0.53	7.58	2.04–19.40*	3	0.29	10.41	2.09–30.40*	1	0.21	4.65	0.06–25.91
Myeloma	4	0.17	24.02	6.46–61.50*	3	0.12	25.90	5.20–75.67*	1	0.05	18.92	0.24–105.25
Non-Hodgkin lymphoma	4	0.14	28.64	7.70–73.32*	3	0.10	30.21	6.07–88.28*	1	0.19	5.21	0.07–28.96
Kaposi sarcoma	3	0.01	446.76	89.79–1305.35*	3	0.08	37.85.	7.61–110.59*
Cervix uteri	3	0.50	6.05	1.22–17.69*					3	0.18	16.73	3.36–48.87*
Prostate	3	1.22	2.45	0.49–7.16	3	0.86	3.49	0.70–10.19
Brain	3	0.23	12.91	2.60–37.73*	1	0.16	6.17	0.08–34.34	2	0.08	26.16	2.94–94.44*
Pancreas	2	0.72	2.79	0.31–10.07	2	0.50	3.97	0.45–14.34
Bladder	2	0.49	4.06	0.46–14.65*	1	0.51	1.95	0.03–10.85	1	0.07	14.61	0.19–81.30
Rectum	2	1.64	1.22	0.13–4.41	1	1.34	0.97	0.01–4.15	1	0.42	2.35	0.03–13.10
Corpus uteri	1	0.50	2.02	0.03–11.23					1	0.19	5.23	0.07–29.11
Ovary	1	0.29	3.40	0.04–18.92					1	0.21	4.86	0.06–27.04
Colon	1	2.08	0.48	0.01–2.67					1	0.61	1.63	0.02–9.09

*p value < 0.05